Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 177,779 |
|
|||||
| News | - | ||||||
| Day High | 39.70 | Low High |
|||||
| Day Low | 38.82 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Halozyme Therapeutics Incorporated | HALO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.455 | 1.17% | 39.425 | 12:20:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.98 | 38.82 | 39.70 | 38.97 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,436 | 177,779 | $ 39.32 | $ 6,989,708 | - | 29.85 - 45.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:20:00 | 100 | $ 39.425 | USD |
Halozyme Therapeutics Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.02B | 126.82M | - | 829.25M | 281.59M | 2.22 | 17.83 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Halozyme Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HALO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.45 | 39.70 | 37.73 | 38.41 | 773,681 | 0.975 | 2.54% |
| 1 Month | 40.51 | 41.60 | 37.73 | 39.55 | 876,743 | -1.09 | -2.68% |
| 3 Months | 33.79 | 42.64 | 33.15 | 38.83 | 1,037,661 | 5.64 | 16.68% |
| 6 Months | 34.96 | 42.82 | 32.83 | 37.60 | 1,167,039 | 4.47 | 12.77% |
| 1 Year | 34.27 | 45.00 | 29.85 | 37.47 | 1,095,702 | 5.15 | 15.04% |
| 3 Years | 50.70 | 59.46 | 29.85 | 41.18 | 1,098,744 | -11.28 | -22.24% |
| 5 Years | 16.44 | 59.46 | 12.71 | 34.80 | 1,192,507 | 22.99 | 139.81% |
Halozyme Therapeutics Description
| Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. |
